Back to SLNCF

UBS Group AG → SLNCF

UBS Group AG SLNCF Position History

Silence Therapeutics plc • Healthcare

Quarters held
14
Latest value
$6.6M
Q3 2026
Peak value
$6.6M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$6K
Q3 2025$1.5M
Q3 2025$78K
Q3 2025$31
Q4 2025$7K
Q4 2025$1.2M
Q4 2025$37K
Q4 2025$5K
Q1 2026$6K
Q1 2026$1.3M
Q2 2026$13K
Q2 2026$2.7M
Q3 2026$46K
Q3 2026$6.6M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$6.6M605.5K——
Q3 2026$46K4.2K——
Q2 2026$2.7M242.0K——
Q2 2026$13K1.2K——
Q1 2026$1.3M245.7K——
Q1 2026$6K1.2K——
Q4 2025$5K839——
Q4 2025$37K6.2K——
Q4 2025$1.2M199.3K——
Q4 2025$7K1.2K——
Q3 2025$316——
Q3 2025$78K15.0K——
Q3 2025$1.5M291.2K——
Q3 2025$6K1.2K——

Other funds holding SLNCF

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B